Literature DB >> 1096622

Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture.

B R Jones.   

Abstract

Effective antifungal therapy must be long-term, nondamaging, penetrating to the eye, and highly active against each patient's fungus. Results of antifungal sensitivity testing of 61 collected ocular fungal pathogens and observations in 25 cases treated with one of the nonpolyene antifungal drugs indicated that infection was rapidly controlled and eradicated with restoration of visual acuity, determined by the degree of disorganization present at the time of commencement of rational specific antifungal therapy. Pimaricin has the widest spectrum, a medium level of activity, and rather poor penetration but is recommended as an antifungal prophylactic and as first-line-therapy for ocular fungal disease while awaiting identification and sensitivity testing of the fungus. Flucytosine combined with amphotericin B, or possibly with clotrimazole or miconazole, is recommended for Candida infections. Clotrimazole is the drug of choice for Aspergillus species although miconazole and econazole are more effective with some isolates. Miconazole and econazole are recommended for miscellaneous filamentous fungi although clotrimazole or thiabendazole are superior in some cases. Each of these drugs may be useful in patients infected with Fusarium who do not respond to primaricin. In these cases, drug use should be guided by the results of antifungal sensitivity testing. In addition to medical antifungal therapy some eyes may require excisional keratoplasty with the lens removal and evacuation of the posterior chamber and anterior vitreous cavity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1096622     DOI: 10.1016/0002-9394(75)90730-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  41 in total

1.  Rhodotorula glutinis keratitis.

Authors:  R Guerra; G M Cavallini; L Longanesi; C Casolari; G Bertoli; F Rivasi; U Fabio
Journal:  Int Ophthalmol       Date:  1992-05       Impact factor: 2.031

2.  Hyalohyphomycosis caused by Paecilomyces variotii: a case report, animal pathogenicity and 'in vitro' sensitivity.

Authors:  J Naidu; S M Singh
Journal:  Antonie Van Leeuwenhoek       Date:  1992-10       Impact factor: 2.271

3.  Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features.

Authors:  Jeena Mascarenhas; Prajna Lalitha; N Venkatesh Prajna; Muthiah Srinivasan; Manoranjan Das; Sean S D'Silva; Catherine E Oldenburg; Durga S Borkar; Elizabeth J Esterberg; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Ophthalmol       Date:  2013-11-05       Impact factor: 5.258

4.  Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi.

Authors:  P A Thomas; A K Leck; M Myatt
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

5.  The pathogenicities of Cylindrocarpon tonkinense and Fusarium solani in the rabbit cornea.

Authors:  Y Ishibashi; H E Kaufman; T Matsumoto; S Kagawa
Journal:  Mycopathologia       Date:  1986-06       Impact factor: 2.574

6.  In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Authors:  Prajna Lalitha; Catherine Q Sun; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Vicky Cevallos; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Am J Ophthalmol       Date:  2013-10-22       Impact factor: 5.258

7.  Current Thoughts in Fungal Keratitis: Diagnosis and Treatment.

Authors:  Zubair Ansari; Darlene Miller; Anat Galor
Journal:  Curr Fungal Infect Rep       Date:  2013-09-01

Review 8.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

9.  Comparative efficacy of amphotericin B, clotrimazole and itraconazole against Aspergillus spp. An in vitro study.

Authors:  Y H Hahn; D G Ahearn; L A Wilson
Journal:  Mycopathologia       Date:  1993-09       Impact factor: 2.574

10.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.